Holen Sie sich die Stockscreener-App
0.88
2.34%
0.0201
Handel nachbörslich:
.89
0.01
+1.14%
Schlusskurs vom Vortag:
$0.8599
Offen:
$0.85
24-Stunden-Volumen:
186.99K
Relative Volume:
0.44
Marktkapitalisierung:
$80.94M
Einnahmen:
$324.00K
Nettoeinkommen (Verlust:
$-82.10M
KGV:
0.4272
EPS:
2.06
Netto-Cashflow:
$-69.18M
1W Leistung:
-15.38%
1M Leistung:
-0.11%
6M Leistung:
-10.89%
1J Leistung:
-9.26%
1-Tages-Spanne:
$0.85
$0.9199
1-Wochen-Bereich:
$0.8301
$1.04
52-Wochen-Spanne:
$0.75
$1.30
Chimerix Inc Stock (CMRX) Company Profile
Firmenname
Chimerix Inc
Sektor
Branche
Telefon
919.806.1074
Adresse
2505 MERIDIAN PARKWAY, SUITE 100, DURHAM, NC
Vergleichen Sie CMRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| CMRX | 0.88 | 80.94M | 324.00K | -82.10M | -69.18M | 2.06 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Chimerix Inc Stock (CMRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-09-07 | Eingeleitet | CapitalOne | Overweight |
| 2021-04-29 | Eingeleitet | Maxim Group | Buy |
| 2021-04-23 | Fortgesetzt | Cowen | Outperform |
| 2021-03-31 | Eingeleitet | Jefferies | Buy |
| 2021-03-31 | Eingeleitet | Wedbush | Outperform |
| 2018-02-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-02-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-08-09 | Bestätigt | FBR Capital | Mkt Perform |
| 2016-02-23 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2016-02-23 | Bestätigt | FBR Capital | Mkt Perform |
| 2016-02-23 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2016-02-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2015-12-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2015-12-28 | Herabstufung | FBR Capital | Outperform → Mkt Perform |
| 2015-12-28 | Bestätigt | Piper Jaffray | Overweight |
| 2015-12-17 | Eingeleitet | UBS | Buy |
| 2015-10-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2015-09-03 | Eingeleitet | Citigroup | Buy |
| 2015-08-18 | Eingeleitet | FBR Capital | Outperform |
| 2015-08-06 | Bestätigt | Brean Capital | Buy |
| 2015-05-11 | Bestätigt | Brean Capital | Buy |
| 2015-03-04 | Eingeleitet | Barclays | Overweight |
| 2015-02-12 | Bestätigt | Stifel | Buy |
| 2014-12-31 | Bestätigt | Brean Capital | Buy |
| 2014-07-08 | Fortgesetzt | Brean Capital | Buy |
Alle ansehen
Chimerix Inc Aktie (CMRX) Neueste Nachrichten
Chimerix (NASDAQ:CMRX) Given Outperform Rating at Wedbush - MarketBeat
Chimerix, Inc. (NASDAQ:CMRX) Short Interest Update - MarketBeat
Chimerix updates officer severance plan, extends term - Investing.com
Chimerix (NASDAQ:CMRX) Earns Buy Rating from HC Wainwright - MarketBeat
Chimerix (CMRX) Announces Updated Phase 2 Response Assessment of Dordaviprone - StreetInsider.com
Chimerix Cancer Drug Shows 28% Response Rate in Phase 2 Brain Tumor Trial | CMRX Stock News - StockTitan
Wedbush Reaffirms “Outperform” Rating for Chimerix (NASDAQ:CMRX) - Defense World
Chimerix, Inc. (NASDAQ:CMRX) Q3 2024 Earnings Call Transcript - Insider Monkey
Chimerix Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Chimerix (CMRX) Reports Q3 Loss, Lags Revenue Estimates - MSN
Earnings call: Chimerix reports progress and financials for Q3 2024 - Investing.com India
Chimerix Inc (CMRX) Q3 2024 Earnings Call Highlights: Strategic Advancements Amid Financial Challenges - GuruFocus.com
Chimerix Inc (CMRX) Q3 2024 Earnings Call Highlights: Strategic Advancements Amid Financial ... - Yahoo Finance
Chimerix: Q3 Earnings Snapshot - CT Insider
Chimerix Inc (CMRX) Quarterly 10-Q Report - Quartzy
Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational Update - The Manila Times
Chimerix Q3 Loss Narrows to $22.9M; Phase 3 Trial On Track with $152.4M Cash Reserve | CMRX Stock News - StockTitan
Chimerix Inc (CMRX) Q3 2024: Everything You Need to Know Ahead o - GuruFocus.com
Chimerix (CMRX) Set to Announce Earnings on Thursday - MarketBeat
Chimerix (NASDAQ:CMRX) Share Price Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat
CMRXChimerix, Inc. Latest Stock News & Market Updates - StockTitan
Chimerix (NASDAQ:CMRX) Stock Price Passes Below 200 Day Moving AverageHere's Why - MarketBeat
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - StockTitan
Smallpox Treatment Market to Experience Holistic Expansion - openPR
Chimerix (NASDAQ:CMRX) Share Price Passes Above 200-Day Moving Average – What’s Next? - Defense World
Chimerix (NASDAQ:CMRX) Stock Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Chimerix, Inc. (NASDAQ:CMRX) Shares Sold by Armistice Capital LLC - Defense World
Glioma Market Size was valued ~USD 650 million in 2023 and - openPR
Copart, Inc. (NASDAQ:CPRT) Shares Sold by Xponance Inc. - Defense World
Investor’s Delight: Compass Inc (COMP) Closes Strong at 6.20, Up 0.16 - The Dwinnex
Copart, Inc. (NASDAQ:CPRT) Shares Acquired by Summit Trail Advisors LLC - Defense World
Pacer Advisors Inc. Has $6.38 Million Stock Position in Copart, Inc. (NASDAQ:CPRT) - Defense World
Intech Investment Management LLC Sells 115,103 Shares of C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) - MarketBeat
Providence Capital Advisors LLC Acquires Shares of 61,800 Microchip Technology Incorporated (NASDAQ:MCHP) - MarketBeat
C.H. Robinson Worldwide (NASDAQ:CHRW) Sets New 12-Month High at $105.70 - Defense World
What is COMP’s price-to-sales ratio telling us about the company’s value? - US Post News
Company’s Banking Stock: Dissecting a -38.92% Quarterly Revenue Decline Amid Growth - The InvestChronicle
Investors in cash trouble should check out Cross Country Healthcares, Inc. (CCRN) - SETE News
C.H. Robinson Worldwide Sees Unusually High Options Volume (NASDAQ:CHRW) - MarketBeat
CHRS stock touches 52-week low at $1.01 amid market challenges - Investing.com India
Balance Sheet Insights: Compass Therapeutics Inc (CMPX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Analytical Overview: Coherus Biosciences Inc (CHRS)’s Ratios Tell a Financial Story - The Dwinnex
Davidson Kempner Capital Management LP Acquires Shares of 150,000 C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) - Defense World
Integral Health Asset Management LLC Buys Shares of 275,000 Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
A stock that deserves closer examination: Coherus Biosciences Inc (CHRS) - US Post News
Mount Yale Investment Advisors LLC Sells 2,003 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Epoch Investment Partners Inc. Buys 29,098 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Here's Why We're Watching Chimerix's (NASDAQ:CMRX) Cash Burn Situation - Yahoo Finance
Barrow Hanley Mewhinney & Strauss LLC Buys 299,721 Shares of Microchip Technology Incorporated (NASDAQ:MCHP) - Defense World
Revenues Working Against Coherus BioSciences, Inc.'s (NASDAQ:CHRS) Share Price Following 27% Dive - Simply Wall St
Pacer Advisors Inc. Boosts Holdings in Cross Country Healthcare, Inc. (NASDAQ:CCRN) - MarketBeat
Finanzdaten der Chimerix Inc-Aktie (CMRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):